Part Details | USP LACTULOSE SOLUTION
6505-01-132-4609
Alternate Parts: NDC00472136016, NDC00472-1360-16, NDC00182607240, NDC00182-6072-40, NDC00182607240, NDC00182-6072-40, NDC00182607240, NDC00182-6072-40, 6505-01-132-4609, 01-132-4609, 6505011324609, 011324609
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAY 30, 1982 | 01-132-4609 | 47950 ( LACTULOSE SOLUTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-132-4609
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00472-1360-16 | 56287 | ACTAVIS ELIZABETH LLCDBA ACTAVIS US |
| NDC00182-6072-40 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC00182-6072-40 | 00E55 | CARDINAL HEALTH, INC.DBA CARDINAL HEALTH |
| NDC00182-6072-40 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-132-4609
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | L473.000$JPT1.000 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | CY10.000 GRAMS LACTULOSE |
| ADMINISTRATION | H$M ORAL, NONCHEWABLE |
| FLAVOR | |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| SPECIAL FEATURES | FOR THE INDICATION OF PORTAL-SYSTEMIC ENCEPHALOPATHY |
| PROTECTIVE STORAGE FEATURE | |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LACTULOSE SOLUTION USP 1PT BT |